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The CD4 coreceptor works together with the T cell receptor (TCR) to deliver signals to the 
developing thymocyte, yet its specific contribution to positive selection and CD4 lineage 
commitment remains unclear. To resolve this, we used N3.L2 TCR transgenic, RAG-, and CD4-
deficient mice, which are severely impaired in positive selection, and asked whether altered 
peptide ligands can replace CD4 function in vivo. Remarkably, in the presence of antagonist 
ligands that normally deleted CD4
 
 
 
 T cells in wild-type mice, we induced positive selection of 
functional CD4 lineage T cells in mice deficient in CD4. We show that the kinetic threshold 
for positive and negative selection was lowered in the absence of CD4, with no evident 
skewing toward the CD8 lineage with weaker ligands. These results suggest that CD4 is 
dispensable as long as the affinity threshold for positive selection is sustained, and strongly 
argue that CD4 does not deliver a unique instructional signal for lineage commitment.
 
T cell development in the thymus results from
interactions between developing thymocytes
and thymic stromal cells, with the outcome
dependent on the avidity of the TCR–pMHC
interaction; high avidity interactions lead to
negative selection, intermediate interactions
lead to positive selection, and weak or no
interactions lead to death by neglect (1, 2).
These interactions are dependent on TCR
recognition of either MHC class I or class II
molecules associated with self-peptides and
with positive selection leading to T cells that
contain cytotoxic (CD8) or helper activity
(CD4), respectively. The coreceptors, CD4
and CD8, play crucial roles in these interac-
tions during T cell development, as they stabi-
lize TCR interactions with their respective
MHC class II or class I molecules (3, 4) and fa-
cilitate the association of signaling molecules
such as Lck and LAT (5, 6). However, in
TCR transgenic mice expressing mutant CD4
or CD8 molecules unable to interact with Lck,
positive selection still occurred (7, 8), and con-
flicting data exists as to whether or not the cy-
toplasmic tail of coreceptors imparts unique
signals directing lineage commitment (9–11).
Therefore, the exact roles of the coreceptors
remain unclear during positive selection and
lineage commitment.
Most studies on the role of peptides in pos-
itive selection and lineage commitment have
focused on the use of MHC class I–restricted
fetal thymic organ cultures (FTOCs), where
they showed that antagonist ligands induced
positive selection of CD8
 
 
 
 T cells (12, 13),
whereas agonists generally induced negative
selection but positive selection at lower con-
centrations (14–19). The role of CD8 during
positive selection has also been assessed in
FTOCs deficient in CD8, showing that posi-
tive selection and CD8 lineage commitment
could be restored by altered peptide ligands
(APLs) of higher affinity (20, 21).
In contrast, little is known about the specific
contribution of the CD4 coreceptor during T
cell development. Studies on the role of pep-
tides in positive selection and lineage commit-
ment of MHC class II–restricted T cells have
been less decisive, as it was impossible to com-
pletely eliminate the presentation of endogenous
class II peptides in MHC class II–restricted
FTOCs. Yet, these studies demonstrated an array
of T cell selection outcomes, from peptide-
specific negative selection (22–24), antagonism
of positive selection (25), to selection of MHC
class II–restricted T cells into the CD8 lineage
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(26). Other approaches addressing the role of peptides on
positive selection and lineage commitment of MHC class II–
restricted T cells have included either a two-step thymic-
reaggregate system (27), adenoviral delivery of invariant
chain–peptide fusion proteins to the thymus (28), or in vivo
injection of soluble peptides (29). Studies have also used
mice expressing a single peptide/MHC class II molecule, ei-
ther via transgenic expression of MHC class II molecules
covalently linked to peptide (30, 31), or mice deficient in
H-2M (32–37), with the results arguing against the role of
specific peptides in selection of a MHC class II–restricted T
cell repertoire. Regardless, none of these studies addressed
the role of CD4 during T cell development. Therefore, al-
though it is recognized that CD4 is important during T cell
maturation, its specific functions during positive selection
and lineage commitment remain unresolved.
However, it is clear that the selection and commitment
of DP T cells to either the CD4 or CD8 T cell lineage is an
asymmetrical process, as different signaling requirements dic-
tate this decision, with one major difference being that CD4
associates with more Lck than does CD8 (5, 38, 39). This
modified version of the instructive model of lineage com-
mitment, termed the “strength-of-signal model,” is widely
accepted as it proposes that CD4 lineage choice is dictated
by TCR signals of either stronger signal intensity (10, 40–
46) or longer/lasting signal duration (27, 47–49). This is in
contrast with the stochastic/selection model, which proposes
that lineage decision is a random process, with further sur-
vival dependent on having the correct TCR and coreceptor
choice (50–52). Initial studies using chimeric molecules con-
sisting of the extracellular domain of CD8 and the cytoplas-
mic domain of CD4 have implicated the cytoplasmic tail of
CD4 as responsible for CD4 lineage commitment (10, 53).
However, another paper using similar chimeric molecules
has argued against this, suggesting instead that the CD4 tail
only determines the number, not the lineage direction of
positively selected thymocytes (11). Additional experiments
obtained from mice deficient in CD4, which showed either
a substantial presence of CD4
 
 
 
CD8
 
 
 
 T cells (7, 54) or a
skewing toward the CD8 T cell lineage (40) along with
studies disrupting CD4–MHC class II interactions (55–57)
or CD4-p56
 
Lck
 
 (7) yielded disparate results, depending on
Figure 1. N3.L2 Rag   CD4    mice are severely impaired in posi-
tive selection with few T cells in the periphery. (A) Lymph node cells 
from N3.L2 Rag   CD4    and N3.L2Rag   CD4    mice were analyzed 
for CD4 and CD8 expression (left). Cells were gated for either CD4 CD8  
cells or CD4 CD8  cells and analyzed for 3.L2 TCR clonotype expression 
(TCR ; right). (B) The number of CD4 CD8 TCR  (black bars), CD4 CD8 TCR  
(white bars), and CD4 CD8 TCR  (black bars, “CD4” positive) cells per 
lymph node from N3.L2 Rag   CD4    and N3.L2 Rag   CD4    mice is de-
picted. Error bars, standard error of the mean. (C) Thymocytes from N3.L2 
Rag   CD4    and N3.L2 Rag   CD4    mice were analyzed for CD4, CD8 
(left), and TCR clonotype expression (right). Histogram gates and numbers 
mark the percentage of total thymocytes that were high for TCR clonotype 
expression (right). (D) TCRhi thymocytes from C were gated and analyzed 
for CD69 expression. 
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the system used. What exactly is the specific contribution of
the CD4 coreceptor during positive selection and lineage
commitment? Does CD4 play different roles during these
two processes? Does CD4 deliver a unique signal for CD4
lineage commitment?
To understand the specific role of the CD4 coreceptor in
T cell ontogeny, we studied MHC class II–restricted T cell
maturation in the absence of CD4 in vivo. We used N3.L2
TCR transgenic mice deficient in RAG and CD4, which
have profound defects in positive selection, with a paucity of
T cells detected in the periphery. Our laboratory has also
previously characterized a unique transgenic system in which
targeted expression of APLs in MHC class II–expressing cells
mediated specific positive and negative selection of 3.L2 T
cells in vivo. With this approach, we have defined a kinetic
threshold of positive and negative selection based on the
half-life of the TCR–pMHC interaction, with long half-
lives leading to negative selection, and shorter half-lives
leading to either enhanced positive selection or no effect
(58–60). Therefore, we asked whether the absence of CD4
would impact this threshold of positive and negative selec-
tion, and subsequently, on CD4 lineage commitment. Our
results show that positive selection could be restored in the
presence of antagonist ligands, with functional T cells of the
CD4 lineage appearing in the periphery. In mice expressing
other APLs, we show that the kinetic threshold for positive
and negative selection was lowered in the absence of CD4.
However, the absence of CD4 did not affect lineage com-
mitment, as there was no skewing toward the CD8 lineage
with weaker ligands. Thus, the present paper clarifies the
role of CD4 during positive selection and argues against the
need of the CD4 coreceptor to deliver a unique instructional
signal for CD4 lineage commitment.
 
RESULTS
Few T cells develop in N3.L2 TCR transgenic mice 
deficient in Rag and CD4
 
For these studies, we used N3.L2 TCR transgenic mice that
expressed receptors (V
 
 
 
18/V
 
 
 
8.3) specific for the hemoglo-
bin peptide (Hb[64–76]) presented by I-E
 
k
 
. To ensure that
we focused on T cells that expressed only the N3.L2 TCR
and not TCRs from endogenous rearrangement of other 
 
 
 
and 
 
 
 
 loci, we crossed these mice with mice deficient in the
 
Rag1
 
 gene (61). As expected, N3.L2 T cells from these mice
(N3.L2 Rag
 
   
 
CD4
 
   
 
) were skewed toward the CD4 lin-
eage, with no CD8 T cells detected in the periphery (Fig. 1,
A and B).
Remarkably, when these mice were additionally crossed
with mice deficient in CD4 (7) (N3.L2 Rag
 
   
 
CD4
 
   
 
),
few T cells developed (Fig. 1). There was a paucity of
CD4
 
 
 
CD8
 
 
 
 T cells in the lymph nodes of N3.L2 Rag
 
   
 
CD4
 
   
 
 mice (
 
 
 
1.5 
 
 
 
 10
 
4
 
 cells/lymph node), a nearly five-
fold decrease in the number of N3.L2 T cells compared with
wild-type mice (
 
 
 
7.2 
 
 
 
 10
 
4
 
 cells/lymph node; Fig. 1 A).
Curiously, we detected only slight skewing toward the CD8
lineage in N3.L2 Rag
 
   
 
CD4
 
   
 
 mice, as few CD8
 
 
 
 T cells
were detected in the periphery (Fig. 1, A and B), less drastic
than the skewing observed in other TCR transgenic mice
deficient in CD4 (40). In the thymus, we detected fewer
TCR
 
hi
 
 cells in N3.L2 Rag
 
   
 
CD4
 
   
 
 mice compared with
wild-type mice (Fig. 1 C), in accordance with the few T
cells detected in the periphery (Fig. 1 B). We also detected
a dramatic decrease in the number and percentage of
TCR
 
hi
 
CD69
 
 
 
 cells in N3.L2 Rag
 
   
 
CD4
 
   
 
 mice com-
pared with wild-type mice (Fig. 1 D). Together, our results
present a unique monoclonal TCR transgenic system in
which the absence of CD4 leads to both severe impairment
of positive selection and very little skewing toward the CD8
lineage, thus allowing us to determine whether we can re-
place the function of CD4 and induce T cell maturation us-
ing APLs.
 
Antagonist ligands can restore positive selection of T cells 
in the absence of CD4
 
We reasoned that if CD4 functioned to enhance the overall
avidity of the TCR–pMHC interaction, then stronger TCR
ligands that normally deleted wild-type T cells should be able
Figure 2. Antagonist ligands can replace CD4 and restore positive 
selection of N3.L2 T cells. (A) Continuum of TCR ligands, with the corre-
sponding Koff (s 1) for each TCR/pMHC interaction (excerpted from refer-
ence 59). (B) Bone marrow cells from N3.L2Rag   CD4    mice were used 
to reconstitute I72 transgenic mice (CD4   →I72), and thymocytes from 
these chimeras were analyzed for CD4, CD8 (left), and TCR clonotype (right) 
expression 8 wk after reconstitution. Histogram gates and numbers denote 
the percentage of total thymocytes that had high TCR clonotype expression. 
(C) Thymocytes from CD4   →I72 chimeras were analyzed for CD4, CD8 
(left) and TCR clonotype expression (middle). Cells were gated for TCRhi and 
analyzed for CD69 expression (right). Histogram gates and numbers denote 
the percentage of cells expressing TCRhi (middle) or CD69 (right). 
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to induce positive selection of N3.L2 T cells in the absence
of CD4. We took advantage of a series of well-defined APLs
for the 3.L2 TCR (58, 59) that were based on mutations of
the primary P5 TCR contact residue, asparagine, at position
72 of the Hb[64–76] peptide (Fig. 2 A). These ligands have
been classified as either an agonist, (Hb[64–76]), weak ago-
nist (T72), strong antagonist (I72), weak antagonist (A72), or
null ligand (Q72, E72) based on their potencies for T cell ac-
tivation (58), and correlate with the longevity of the TCR–
pMHC interaction (Fig. 2 A and reference 59). More impor-
tantly, we have previously created transgenic mice in which
all class II–positive cells express functional APL activity in
vivo, with agonists and antagonists mediating negative selec-
tion, and null ligands expressing enhanced positive selection
or no effect in vivo (60, 62). Therefore, we sought to deter-
mine whether any of these APLs could increase thymocyte
avidity sufficiently in the absence of CD4 and restore posi-
tive selection of N3.L2 Rag
 
   
 
CD4
 
   
 
 T cells in vivo.
For our initial experiments, we chose an APL of inter-
mediate TCR ligand strength, an antagonist (I72), which has
previously been shown to delete 3.L2 CD4
 
 
 
 T cells (60).
We made radiation chimeras with bone marrow cells from
CD4
 
   
 
 or CD4
 
   
 
 mice and reconstituted host mice ex-
pressing I72 (denoted as CD4
 
   
 
→
 
I72 and CD4
 
   
 
→
 
I72)
and examined T cell selection in these chimeras (Fig. 2, B
and C). As expected, negative selection was detected in
CD4
 
   
 
→
 
I72 chimeras, evident by the paucity of TCR
 
hi
 
thymocytes (Fig. 2 B) and absence of peripheral clonotype
positive (denoted as TCR
 
 
 
) T cells (Fig. 3 D). In contrast,
positive selection was restored in CD4
 
   
 
→
 
I72 chimeras, as
we detected a dramatic increase in TCR
 
hi
 
 thymocytes (Fig. 2
C), up-regulation of CD69 expression (Fig. 2 C), and in-
crease in the percentage (Fig. 3 A) and number (see Fig. 5 B)
of CD4
 
 
 
CD8
 
 
 
TCR
 
 
 
 T cells in the periphery. These results
suggest that increasing thymocyte avidity with antagonist
ligands can replace CD4 coreceptor function and restore
positive selection of N3.L2 Rag
 
   
 
CD4
 
   
 
 T cells in vivo.
 
I72-selected CD4
 
   
 
 T cells commit to the CD4 lineage
 
Positive selection of I72-selected CD4
 
   
 
 T cells resulted in a
predominantly CD4
 
 
 
CD8
 
 
 
 T cell population in the lymph
nodes, with few cells skewed toward the CD8 lineage (Fig. 3
A). Because these I72-selected CD4
 
 
 
CD8
 
 
 
TCR
 
 
 
 T cells
cannot express surface CD4, a marker for commitment to the
CD4 lineage, it was possible that these cells were not of the
CD4 lineage and belonged to an alternative lineage. To ad-
dress this, we attempted to detect CD4 mRNA using primers
specific to exons 1–5 upstream of the Neo insertion site (63),
reasoning that CD4
 
 
 
CD8
 
 
 
TCR
 
 
 
 T cells in these chimeras
should express this truncated CD4 mRNA indicative of their
commitment to the CD4 lineage. This was shown in Fig. 3
B, where by RT-PCR, we detected CD4 message in CD4
 
 
 
CD8
 
 
 
TCR
 
 
 
–sorted thymocytes, splenocytes, and lymph
node cells from the CD4
 
   
 
→
 
I72 chimeras. The lower levels
of CD4 message in the CD4
 
   
 
→
 
I72 chimeras is probably
due to instability of the message as a result of the Neo inser-
tion in the CD4 message. No CD4 message was detected in
CD8
 
 
 
 T cells from B6.K (Fig. 3 B) or N3.L2 CD4-deficient
mice (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20041574/DC1). In addition, we were able to iden-
Figure 3. Phenotypic analysis of peripheral T cells from CD4   →I72 
chimeras. (A) Lymph node cells from CD4   →I72 mice were gated on 
CD4 CD8  (left) or CD4 CD8  (right) expression and analyzed for TCR 
clonotype expression. Histogram gates and numbers denote the percent-
age of cells that were positive for TCR clonotype expression. Data are rep-
resentative of at least three similar experiments, with two to four mice per 
group. (B) Total RNA from an equivalent number of sorted CD4  or CD8  T 
cells from B6.K mice and sorted CD4 CD8 TCR  thymocytes, splenocytes, 
or lymph node cells was extracted, reverse transcribed, and PCR-amplified 
for exons 1–5 of CD4, upstream of the Neo cassette. (C) TCR clonotype 
positive lymph node cells from CD4   →I72 mice were analyzed for CD62L, 
CD44, and CD25 expression. Histogram gates and numbers mark the per-
centage of cells that were negative for CD8 and positive for TCR clonotype 
expression. (D) Lymph node cells from CD4   →B6.K, CD4   →I72, 
CD4   →B6.K chimeras were gated on CD4 CD8  (left) or CD4 CD8  
(middle and right) and analyzed for TCR clonotype expression.JEM VOL. 201, January 3, 2005 153
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tify DN thymocytes (CD4 CD8 TCR ) that did not ex-
press truncated CD4 message in N3.L2 CD4-deficient mice,
ruling out the possibility that premature expression of the
TCR transgene in DN thymocytes was responsible for CD4
T cell development (Fig. S1). Moreover, the CD4 CD8 
TCR  T cells from CD4   →I72 chimeras cells were nega-
tive for CD8  (Fig. 3 A), B220, NK1.1,    TCR (not de-
picted), and CD25 (Fig. 3 C), ruling out the possibility that
these cells belonged to other T cell lineages such as the
CD8   intraepithelial, DN B220 , NKT,   , or T regula-
tory cell lineages, respectively. Together, these results show
that the CD4 CD8 TCR  T cells selected by antagonist
ligands were CD4 lineage T cells.
It is also possible that the phenotype observed in CD4   
→I72 mice represents enhanced homeostatic proliferation of
few selected T cells, rather than efficient positive selection by
antagonist ligands. We believe this to be unlikely, as the I72-
selected CD4    T cells were predominantly of the naive
phenotype, expressing CD44lo and CD62Lhi, and not activa-
tion markers such as CD25 (Fig. 3 C) or CD69 (not de-
picted), suggesting that these cells were quiescent and not ac-
tively proliferating in the periphery. Also, in control chimeras
expressing no APLs (CD4   →B6.K, CD4   →B6.K; Fig. 3
D), positive selection was similar to wild-type N3.L2 Rag   
CD4    and N3.L2 Rag   CD4    mice (Fig. 1 A), suggest-
ing that bone marrow chimeras faithfully recapitulate positive
selection seen in wild-type mice. In fact, positive selection
was similar between CD4   →I72 and CD4   →B6.K mice
(see Fig. 5 A), with more CD4 CD8 TCR  peripheral T
cells detected in the former than the latter (see Fig. 5 B).
Thus, these results further substantiate our observation that
antagonists can replace CD4 and mediate efficient positive se-
lection of CD4 lineage T cells in vivo.
I72-selected CD4    T cells respond to Hb(64–76), 
and not to APLs
Another hallmark of successful positive selection and CD4
lineage commitment is the presence of functional MHC
class II–restricted T cells in the periphery. We tested the
I72-selected CD4    T cells for two parameters characteris-
tic of functional wild-type 3.L2 T cells as follows: (a) their
ability to proliferate and produce IL-2 in response to
Hb(64–76), and (b) their graded responses to APLs (58, 60,
62). As shown in Fig. 4 A, I72-selected CD4    T cells re-
sponded vigorously to Hb(64–76) in the proliferation as-
say, confirmed by detection of IL-2 production using the
CTLL-2 bioassay (Fig. 4 B). When tested for their response
to APLs, I72-selected CD4    T cells proliferated weakly to
the weak agonist (T72; Fig. 4 A), correlating with low lev-
els of IL-2 production (Fig. 4 B). Not surprisingly, I72-
selected CD4    T cells did not proliferate or produce IL-2
in response to either the antagonist (I72) or null ligand
(Q72). Together, these results demonstrate that the antago-
nist ligand (I72) promoted successful positive selection and
CD4 lineage commitment of functional MHC class II–
restricted N3.L2 CD4    T cells.
Positive selection and lineage commitment of T cells in the 
presence of other APLs
We expanded our analysis to include chimeras expressing
other APLs in the presence or absence of CD4. Confirming
our previous findings, negative selection ensued in CD4   
chimeras that expressed antagonists, weak agonists, or ago-
nists, with few CD4 CD8 TCRhi SP thymocytes detected
in these mice (Fig. 5 A). With the weaker ligand (Q72), we
detected an increase in the number of CD4 CD8 TCRhi
SP thymocytes, slightly higher than in control CD4   
→B6.K (no APL) chimeras (Fig. 5 A), consistent with en-
hanced positive selection described previously (60). These
results confirm our previous finds in APL transgenic mice,
and indicate that the selection seen was apparently not influ-
enced by the absence of I72-expressing bone marrow–
derived cells in the radiation chimeras.
In contrast, a different pattern emerged in chimeras defi-
cient in CD4 as follows: (a) with antagonists (I72), we de-
Figure 4. T cells from CD4   →I72 chimeras respond to Hb(64–76), 
and not to APLs. (A) Splenocytes from CD4   →I72 mice were har-
vested, pooled, depleted of MHC class II–positive cells, and tested for their 
ability to respond to different APLs in a proliferation assay. Antigen used: 
Hb(64–76) (squares); T72 (triangles); I72 (circles); and Q72 (diamonds). 
Background proliferation in the absence of antigen was 600 cpm. Data are 
representative of three similar experiments. (B) One fourth of the culture 
supernatant from A was collected 24 h after the initial antigen stimulation 
and IL-2 production was measured using the CTLL-2 bioassay 48 h later.POSITIVE SELECTION OF T CELLS BY AN ANTAGONIST | Kao and Allen 154
tected a dramatic increase in the number of CD4 CD8 
TCRhi cells in the thymus, consistent with restored positive
selection in the thymus (Fig. 2 C) and lymph nodes (Figs. 3
A and 5 B); (b) with the weak agonist (T72) or agonist
(Hb[64–76]), few CD4 CD8 TCRhi SP thymocytes could
be detected, suggesting the onset of negative selection (Fig. 5
A), although for CD4   →T72 chimeras, some weak posi-
tive selection of CD4 CD8 TCR  lymph node T cells
could still be detected (Fig. 5 B); (c) with the weaker ligand
(Q72), we detected a lower number of CD4 CD8 TCRhi
SP thymocytes, indicative of weak positive selection; and (d)
in control CD4   →B6.K (no APL) chimeras, although
there was some variability in the number of CD4 CD8 
TCRhi SP thymocytes (Fig. 5 A), the paucity of CD4 
CD8 TCRhi T cells in the lymph nodes (Fig. 5 B) was still
consistent with impairment of positive selection in the ab-
sence of CD4. Similar results with I72 were obtained with
mice expressing the weak antagonist (A72), and Q72 with
the other null ligand, E72 (unpublished data). Together, we
show that the kinetic threshold for positive and negative se-
lection was lowered in the absence of CD4, implying that
the function of CD4 can be replaced by increasing the affin-
ity of the TCR–pMHC interaction.
The central tenet of the strength-of-signal model is that
strong TCR signals promote CD4 lineage commitment,
whereas weaker ligands would skew development toward the
CD8 lineage. Therefore, we wanted to test whether differen-
tial lineage commitment would occur using a spectrum of
TCR ligands in the absence of CD4. As shown in Fig. 5 B,
whereas the agonist ligand (Hb[64–76]) lead to complete
negative selection and absence of both CD4 and CD8 lineage
T cells in the periphery, the weak agonist (T72) lead to partial
positive selection of CD4 lineage (CD4 CD8 TCR ) T
cells. With antagonist ligands (I72), we detected maximal
positive selection and CD4 lineage commitment, although a
slight increase in CD8 lineage T cells (CD4 CD8 TCR )
was also observed (Fig. 5 B). However, with the ligand of the
lowest affinity in this group (Q72), we detected few
CD4 CD8 TCR  T cells, even though slight positive selec-
tion of CD4 lineage cells was detected. In chimeras express-
ing no APLs (CD4   →B6.K), we detected few CD8 lin-
eage T cells, consistent with the phenotype observed in
N3.L2 Rag   CD4    mice. Together, we have conclu-
sively shown that CD4 lineage commitment can occur in the
absence of CD4, thus demonstrating that CD4 does not de-
liver a unique signal for CD4 lineage commitment.
DISCUSSION
Many studies have demonstrated that the CD4 and CD8 core-
ceptors play crucial roles during T cell development, yet it has
been difficult to ascertain their specific roles during positive se-
lection and lineage commitment. Most studies have focused
exclusively on MHC class I–restricted T cells, showing that
CD8 is not crucial for CD8 lineage commitment if selected
with low affinity peptides (20, 21). In contrast, few studies
have been done to address these same issues for the CD4 core-
ceptor on the development and maturation of MHC class II–
restricted T cells. To resolve this, we asked whether positive
selection could be restored in N3.L2 Rag   CD4    mice,
which are severely impaired in positive selection. Our results
show the following: (a) positive selection of functional MHC
class II–restricted T cells can occur with low affinity peptides
in the absence of CD4, and (b) the kinetic threshold for posi-
tive and negative selection is lowered in the absence of CD4.
Together, our results imply that CD4 does not deliver a
unique signal for CD4 lineage commitment.
In this paper, we present evidence that TCR antagonist
ligands can restore positive selection of CD4 lineage T cells
in the absence of CD4. Remarkably, this same ligand in-
duces negative selection in the presence of CD4, implying
that the kinetic threshold for positive and negative selection
was lowered by the absence of CD4. We interpret these re-
Figure 5. T cell maturation in chimeras expressing other APLs. 
(A) Thymocytes from various CD4   →APL (black bars) and CD4   →APL 
chimeras (white bars) were analyzed for CD4, CD8 and TCR clonotype 
expression. The number of CD4 CD8 TCRhi (CD4   ) or CD4 CD8 TCRhi 
(CD4   ) cells is depicted. (B) Lymph node cells from various CD4   →APL 
chimeras were analyzed for CD4, CD8 and TCR clonotype expression, and 
the number of CD4 CD8 TCR  (black bars) or CD4 CD8 TCR  (white 
bars) cells per lymph node is depicted. As a control, CD4 TCR  (black bars) 
and CD8 TCR  (white bars) cells from CD4   →B6.K (no APL) are depicted 
(right). Data are representative of two to three similar experiments, with 
two to four mice per group.JEM VOL. 201, January 3, 2005 155
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sults to indicate that an increase in the affinity of the TCR
ligand can replace the function of CD4 and restore positive
selection. If so, perhaps the main function of CD4 during T
cell development is to bind and stabilize TCR–pMHC in-
teractions and increase the half-life of TCR–pMHC com-
plexes, as has been proposed previously (64, 65). This model
proposes that CD4 can effectively increase the half-life of
preformed TCR–pMHC complexes, provided that the
TCR–pMHC interaction is of sufficient duration to allow
CD4 to be recruited to the immunological synapse, where it
can also associate with self-peptide–MHC complexes to
form a CD4 “pseudodimer” (66). This interpretation would
be compatible with studies in which disruption of CD4–
MHC class II interactions blocked CD4 T cell development
(56) and disruption of CD4-p56 Lck had no effect provided
that the mutant CD4 was overexpressed (7). Therefore, in
the absence of CD4, we would predict that the half-life of
TCR–pMHC complexes is shorter, and not of sufficient du-
ration to transmit enough signals to achieve the minimum
threshold needed for positive selection. In contrast, when
compensated with a TCR ligand that has a longer half-life
(antagonist), sufficient interaction is acquired to cross the
minimum threshold for positive selection. With TCR li-
gands that have an even longer half-life (agonists or weak
agonists), negative selection ensues, implying that no advan-
tage is obtained by CD4 in stabilizing and maintaining an al-
ready long-lived TCR–pMHC interaction. Collectively,
our results imply that during positive selection, CD4 is pri-
marily required for maintaining the avidity of the TCR–
pMHC interaction, and is nonessential in providing a quali-
tative signal for T cell development.
Previous studies have documented that the absence of
CD4 leads to the development of MHC class II–restricted T
cells into the CD8 lineage (40). This, along with initial stud-
ies using CD8/CD4 chimeric molecules, leads to the pro-
posal of the initial strength-of-signal model, which proposes
that coreceptors dictate T cell lineage choice (9, 10, 53). Our
results challenge this model in the following ways: (a) we de-
tected little skewing toward the CD8 lineage in N3.L2
Rag   CD4    mice; (b) we detected slight skewing toward
the CD8 lineage in CD4   →I72 mice; and (c) we were un-
able to push the cells completely into the CD8 lineage with
the weakest TCR ligand used in this paper, Q72. Together,
we provide evidence that CD4 does not impart unique sig-
nals that determine CD4 lineage commitment. In fact, our
studies agree with a previous paper arguing that the CD4 and
CD8 tails do not dictate lineage decision (11). Collectively,
our results in conjunction with studies citing the nonessential
requirement for CD8 in CD8 lineage commitment conclu-
sively rules out the role of coreceptors in lineage decision,
and thus challenge the original strength-of-signal model for
lineage commitment. Consequently, this would imply that
information about MHC class specificity is delivered exclu-
sively by the TCR, and not by the coreceptors. Moreover,
our results and others would imply that the primary role of
the coreceptors during thymocyte development is for posi-
tive selection, where they serve to stabilize their respective
TCR–MHC complexes, associate with Lck, and allow for
the transmission of the “selecting signal,” of either the right
intensity, duration, or both, to the developing thymocyte.
However, it would seem that the affinity requirement for
positive selection of CD4 SP thymocytes is less stringent than
that of CD8 SP thymocytes, as CD8 T cell development is
more severely impaired in CD8-deficient mice compared
with its CD4 counterpart in CD4-deficient mice. Exactly
how the coreceptors contribute to the affinity required for
selection into the CD8 or CD4 lineage is still a matter of in-
tense debate and investigation, and may be revealed as more
precise measurements of the coreceptors interactions with
their respective MHC molecules are obtained.
This paper is the first to demonstrate that CD4 is not an
absolute requirement for CD4 lineage commitment. Our re-
sults also do not favor the stochastic/selection model because
we detected primarily only CD4 lineage T cells instead of
equal frequencies of MHC class II–restricted T cells in both
CD4 and CD8 lineages in any of the CD4-deficient bone
marrow chimeras. However, we cannot argue against revised
versions of the strength-of-signal model, which are based on
quantitative differences in either signal intensity or signal du-
ration (for review and discussion see references 67, 68), ex-
cept that these signals can be delivered exclusively by the
TCR alone, provided that the TCR–pMHC interaction is
of sufficient affinity. In fact, our results can be interpreted in
light of these quantitative models, as with different TCR
ligands, we were able to manipulate the kinetic thresholds of
positive and negative selection. However, one caveat re-
mains as to why we could not detect CD8 lineage T cells
with the null ligand, Q72. It is possible that other weaker
ligands may redirect cells toward the CD8 lineage, with a
Koff faster than Q72, but still of sufficient affinity for positive
selection. It is also possible that the natural intrinsic affinity
of the N3.L2 TCR for pMHC is higher than other MHC
class II–restricted TCRs, such that even in the absence of
CD4, the signal strength is still not low enough to skew to-
ward the CD8 lineage. It is also important to point out that
in those studies, skewing toward CD8 lineage T cells in
CD4-deficient mice was most evident in mice heterozygous
for its selecting MHC (i.e., selection of AND under H-2bxk,
or selection of DO10 under H-2dxb), whereas in anti-HA
TCR transgenic CD4-deficient mice, very little skewing to-
ward the CD8 lineage under H-2dxd was observed (40).
Therefore, perhaps for the N3.L2 TCR, lower I-Ek levels
might lead to redirection toward the CD8 lineage.
A set of studies has suggested that signals specifying CD4
T cell lineage commitment may be distinct from signals that
mediate positive selection (69, 70). Our results support this
contention, as we show the requirement of CD4 in positive
selection, but not in CD4 lineage commitment. Thus, under
normal conditions in which mice express the full complement
of a normal T cell repertoire and the CD4 coreceptor, it is
possible that CD4 functions primarily to stabilize weak/tran-
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repertoire, as suggested in previous studies (35, 37, 71, 72).
Although it is still unclear what specific signals dictate lineage
choice, we have clarified the role of the CD4 coreceptor dur-
ing T cell development. In conclusion, our findings strongly
support the concept that it is the strength of the specific
TCR–pMHC interaction that delivers the instructive signal
for CD4 lineage commitment, not the CD4 coreceptor.
MATERIALS AND METHODS
Transgenic mice. N3.L2 mice, which express the 3.L2 TCR–recognizing
Hb(64–76)/I-Ek, have been described previously (73, 74). The original 3.L2
mice (75) contained a single base error in the J  segment, leading to a single
amino acid difference with the TCR from the 3.L2 T cell hybridoma (73);
the N3.L2 mice used herein contain the corrected 3.L2 TCR. No difference
in T cell reactivity to APLs or T cell development was observed between
3.L2 and N3.L2 mice. In addition, N3.L2 mice crossed onto mice expressing
various APL transgenes lead to results indistinguishable from those of 3.L2
mice (unpublished data). N3.L2 Rag    mice was generated by crossing
N3.L2 mice with RAG1.AKR mice, which is based on a cross between the
RAG1-deficient strain, C57BL/6J-Rag1tm1 Mom (The Jackson Laboratory)
and B6.AKR (H-2k, denoted as B6.K) mice. These mice were crossed with
CD4-deficient mice (63) to generate N3.L2 Rag   CD4    mice. Trans-
genic expression of Hb(64–76) or one out of five different APLs as an
epitope tag within a membrane form of hen egg-white lysozyme (mHEL/
APL; references 60, 62) is driven by the E  promoter such that transgene ex-
pression is effectively targeted in MHC class II–expressing cells (76). All
progeny were screened by PCR analysis of tail DNA for the N3.L2 TCR
and mHEL/APL transgenes. All mice were bred and housed under specific
pathogen-free conditions in the animal facility at the Washington University
Medical Center. All animal experiments followed protocols that were ap-
proved by the Washington University Animal Studies Committee.
Peptides. The peptides used in this work were synthesized, purified, and
analyzed as described previously (58, 75). APLs have been defined previ-
ously and are denoted as the one-letter amino acid code of the substituted
amino acid at position 72 (Fig. 2 A). The amino acid sequences for the pep-
tides used in this work are as follows: Hb(64–76), GKKVITAFNEGLK;
T72, GKKVITAFTEGLK; I72, GKKVITAFIEGLK; and Q72, GKKVI-
TAFQEGLK.
Radiation bone marrow chimeras. To construct bone marrow chime-
ras, 6–12-wk-old recipient mice were lethally irradiated with 1,100 rad
(137Cs source; Gammacell 40) and reconstituted with 5–10   106 bone mar-
row cells that have been depleted of mature T and B cells by treatment with
anti-CD3 PE (145-2C11) and anti-B220 PE (RA3-6B2), followed by re-
moval using MACS Microbeads conjugated with anti-PE (Miltenyi Biotec).
Reconstituted mice were kept on antibiotic water and analyzed  8 wk later.
Flow cytometry and electronic sorting. The antibodies used in this
study were CD4-PE (H129.19), CD8 -FITC (53-6.7), CD69-PE (H1.2F3),
CD25-PE (PC61), CD62L-PE (MEL-14), CD44-FITC (IM7), Cab-biotin
(mouse anti-3.L2 TCR clonotype), G155-178-biotin (mouse anti-TNP,
IgG2a isotype control), and streptavidin-tricolor (Caltag Laboratories). Ex-
cept where noted, all antibodies were purchased from BD Biosciences. Single
cell suspensions of thymocytes or lymph node cells were stained with primary
antibodies in FACS buffer (PBS with 0.5% BSA and 0.1% NaN3) for 45 min
on ice, washed twice with FACS buffer, and where necessary, stained with
secondary antibodies for 30 min on ice. Cells were washed and fixed in 2%
paraformaldehyde. Samples were analyzed on a FACScan (Becton Dickinson)
using CellQuest analysis software. For electronic cell sorting, thymocytes,
lymph node cells, or splenocytes were stained with CD4-PE, CD8 -FITC,
and/or Cab-biotin (followed by streptavidin-tricolor), and sorted by a FACS
Vantage SE (Becton Dickinson) gated on CD4 CD8 Cab  (for CD4   
→I72), CD4 , or CD8  (B6.K mice) expression.
Detection of CD4 mRNA by RT-PCR. Total cellular RNA from
sorted cells as described in the figure legends was extracted with TRIzol fol-
lowing the manufacturer’s protocol (Invitrogen). RNA was reverse tran-
scribed into first-strand cDNA using random hexamers and AMV reverse
transcriptase (Promega). PCR amplification was done using primers specific
for exons 1–5 of CD4, upstream of the neo insertion site (63) (CD4 for-
ward: 5 -GTCACTCAAGGGAAGACGCTGGTG-3 , CD4 reverse: 5 -
AAGGTCACTTTGAACACCCACAAC-3 ) under the following cycling
conditions: 38 cycles of 30 s at 94 C, 30 s at 60 C, and 1 min at 72 C.
T cell proliferation assay and measurement of IL-2 production.
Splenocytes from CD4   →I72 mice were harvested, pooled, and depleted
of MHC class II–positive cells to avoid peripheral antagonism (62, 77). De-
pletion of MHC class II–positive cells was done by staining cells with the
class II–specific 14-4-4 antibody, followed by removal using MagaBeads
conjugated with goat anti–mouse IgG (Cortex Biochem Inc.). For prolifera-
tion assays, 3.5   105 cells/well were incubated with 5   105 irradiated sple-
nocytes from B6.K mice loaded with increasing amounts of peptide for 48 h,
pulsed with 0.4  Ci [3H]thymidine, and harvested 18–24 h later. For mea-
surement of IL-2 production, one fourth of each well was collected 24 h af-
ter antigen stimulation and transferred to the IL-2 indicator cell line, CTLL-2,
for 24 h, pulsed with 0.4  Ci [3H]thymidine, and harvested 24 h later.
Online supplemental material. Fig. S1 demonstrates that the truncated
CD4 message is not detected in CD4 CD8 TCR  thymocytes, or in CD8 
T cells from N3.L2 CD4-deficient mice. Online supplemental material is
available at http://www.jem.org/cgi/content/full/jem.20041574/DC1.
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